ACB $6.790 (0.15%)

ACNNF $0.063 (-3.38%)

AERO $3.210 (0%)

ALEAF $0.123 (0%)

AMMJ $0.090 (0%)

APHA $15.380 (0%)

ARNA $57.420 (-2.61%)

ATT:CNX $0.080 (0%)

AUSA:CNX $0.170 (-5.56%)

AUSAF $0.140 (-0.21%)

AVXL $19.450 (2.42%)

BAMM:CNX $0.440 (-3.3%)

BBM:CNX $0.065 (-7.14%)

BBRRF $0.055 (0%)

BE:CNX $0.005 (0%)

BIO:CNX $0.035 (0%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.640 (-1.54%)

BLOZF $0.510 (0%)

BUDZ $0.299 (-1.97%)

CADMF $0.199 (-3.03%)

CALI:CNX $0.025 (25%)

CANN $0.361 (0.84%)

CARA $12.800 (-4.05%)

CBWTF $0.169 (-6.75%)

CGC $11.690 (-1.52%)

CGRW $0.065 (-0.15%)

CHOO:CNX $0.050 (11.11%)

CHOOF $0.037 (-6.5%)

CNBX $0.136 (2.94%)

CNGGF $0.203 (0%)

CODI $30.160 (-3.08%)

CPMD $0.021 (-5.41%)

CRBP $0.884 (-3.06%)

CRON $4.670 (-2.91%)

CROP:CNX $0.015 (0%)

CSI:CNX $0.250 (-3.85%)

CURR $0.423 (-11.05%)

CVSI $0.195 (-4.88%)

DIGP $0.034 (4.45%)

DXBRF $0.055 (-3.51%)

EEVVF $0.120 (9.51%)

EMHTF $0.058 (0.45%)

EPWCF $0.212 (-6.43%)

EVIO $0.001 (0%)

FFT:CNX $0.040 (0%)

FNNZF $0.015 (-15.24%)

GNBT $0.093 (12.12%)

GRIN:CNX $0.115 (0%)

GRWG $17.990 (-1.8%)

GTBIF $23.200 (1.24%)

GTII:CNX $29.200 (-1.35%)

GWPH $218.960 (0%)

HEXO $1.190 (-0.83%)

HHPHF $0.185 (0%)

HLSPY $0.363 (0%)

HMLSF $5.751 (-2.56%)

HMPPF $0.498 (0%)

HRVOF $0.060 (0%)

HSTRF $0.181 (0.39%)

HUGE:CNX $1.730 (0.58%)

IAN:CNX $0.210 (0%)

IGC $1.360 (-2.86%)

IGXT $0.509 (-3.98%)

IIPR $266.460 (-0.97%)

INQD $0.014 (0.74%)

IONC:CNX $0.040 (-27.27%)

IONKF $0.034 (-14.5%)

ISOL:CNX $0.035 (0%)

ISOLF $0.004 (0%)

ITHUF $0.172 (-1.12%)

IVITF $0.005 (0%)

KALTF $0.120 (4.35%)

KBEV:CNX $0.045 (0%)

KHRNF $0.178 (-0.53%)

KSHB $0.695 (0%)

LHS:CNX $1.470 (0%)

LHSIF $1.145 (0%)

LXX:CNX $8.400 (0%)

MCIG $0.028 (0%)

MEDIF $0.172 (-4.26%)

MGWFF $0.073 (10.76%)

MJ:CNX $0.210 (5%)

MJNA $0.024 (-3.69%)

MNTR $0.087 (3.57%)

MYM:CNX $0.140 (0%)

MYMMF $0.106 (0%)

NCNNF $0.058 (0%)

NDVAF $0.242 (-7.07%)

NGW:CNX $0.350 (-1.41%)

NRXCF $0.057 (0%)

NSPDF $0.022 (7.75%)

NVTQF $0.848 (0%)

NWKRF $0.424 (0%)

NXGWF $0.274 (-4.85%)

NXTTF $0.061 (-3.68%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

PHCG $0.200 (-4.81%)

PHVAF $0.038 (0%)

PILL:CNX $0.700 (-2.78%)

PKG:CNX $0.090 (0%)

PLPRF $0.357 (0%)

PLUS:CNX $0.440 (0%)

PMCB $2.500 (-7.06%)

PNPL $0.010 (0%)

PTNYF $0.073 (-7.52%)

QCA:CNX $0.160 (-5.88%)

RDDTF $0.041 (-7.87%)

RLLVF $0.013 (0%)

RMHB $0.002 (0%)

RQB:CNX $0.005 (0%)

RQHTF $0.985 (-1.53%)

SLNG:CNX $0.110 (-4.35%)

SMG $161.430 (-1.82%)

SNN:CNX $0.155 (0%)

SOL:CNX $3.730 (-1.58%)

SOLCF $2.910 (-1.72%)

SPLIF $0.102 (0.79%)

SPRWF $0.268 (0%)

SRNA $0.049 (2.75%)

STEM:CNX $0.200 (-6.98%)

STMH $0.160 (-6.26%)

SUN:CNX $0.150 (0%)

TBPMF $0.150 (-1.48%)

TCAN:CNX $0.540 (-8.47%)

TCNAF $0.450 (-2.17%)

TER:CNX $8.200 (-2.96%)

TGEN $1.410 (0%)

TGIF:CNX $0.065 (8.33%)

TGIFF $0.049 (-4.69%)

THC:CNX $0.090 (-5.26%)

THCBF $0.073 (-3.27%)

TLRY $10.570 (-3.03%)

TRLFF $0.170 (5.59%)

TRSSF $6.580 (1.08%)

TURV $0.005 (0%)

VIDA:CNX $0.055 (0%)

VIN:CNX $0.080 (6.67%)

VPRB $0.053 (4.79%)

VRT:CNX $0.450 (0%)

VRTHF $0.131 (0%)

VVCIF $0.075 (0.13%)

WAYL:CNX $0.740 (0%)

XXII $2.600 (-6.47%)

ZDPY $0.880 (0%)

ZYNE $3.600 (-2.17%)

Technical420 Site Search

Returned 40 result(s).

CanniMed Signs Letter of Intent with Pharmasave

Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) and CanniMed Therapeutics Inc. (TSX: CMED) announced today that CanniMed has entered into a Letter of Intent to become a preferred supplier of medical cannabis to Pharmasave. A member governed cooperative of more than 650 independently owned community pharmacies across the country, Pharmasave…

Andrċ Jérôme Appointed Interim CEO of CanniMed

Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. ("CanniMed") (TSX: CMED) announced today that Mr. Brent Zettl has resigned from his position as CEO of CanniMed, effective immediately, to pursue other opportunities. Mr. Zettl has agreed to remain available to CanniMed and…

CanniMed Therapeutics Inc. Announces First Quarter Results

CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its unaudited financial results of operations for the three months ended January 31, 2018. The information in this news release should be read in conjunction with the Company’s condensed consolidated interim financial statements and notes thereto (unaudited) for the three…

Aurora Cannabis and CanniMed Therapeutics File Offer Documents for Previously Announced Friendly Acquisition

Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. (“CanniMed”) (TSX: CMED) today announced the filing of Aurora’s Notice of Variation and CanniMed’s Notice of Change to Directors’ Circular (collectively the “Offer Documents”) in connection with Aurora’s improved offer to acquire all of…

CanniMed Therapeutics Inc. Reports Financial Results for 2017

CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its financial results for the fiscal year ended October 31, 2017. Highlights Sales of $16.7 million in 2017 were 70% higher than 2016.Concentrated cannabis oils sales revenues were approximately 51% of total revenues for the year, compared to 31% of…

Aurora Cannabis and CanniMed Therapeutics Agree to Terms on Friendly Transaction

Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. (“CanniMed”) (TSX: CMED) announce today that they have entered into a support agreement (the “Support Agreement”) whereby the Board of Directors and the Special Committee of the CanniMed Board have agreed to support a…

Newstrike Resources Ltd. Provides Update on Arrangement Transaction

Newstrike Resources Ltd. ("Newstrike" or the "Company") (TSX VENTURE:HIP) announces that pending the results of discussions among Aurora Cannabis Inc. ("Aurora") and CanniMed Therapeutics Inc. ("CanniMed"), it has adjourned the hearing for the final court order in connection with the plan of arrangement relating to the acquisition by CanniMed of Newstrike…

CanniMed Therapeutics Announces Continued Discussions with Aurora Cannabis

CanniMed Therapeutics Inc. (TSX:CMED) announces that it is continuing to discuss terms of a possible transaction with Aurora Cannabis Inc. (“Aurora”). Therefore, CanniMed and Aurora have each agreed to extend their previously announced standstill to expire at 5:00 pm (EST) today, and until such time (i) neither CanniMed nor Aurora…

CanniMed Therapeutics Announces Continuation of Discussions with Aurora Cannabis

CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX:CMED) announces that it is continuing to discuss terms of a possible transaction with Aurora Cannabis Inc. (“Aurora”). Therefore, CanniMed and Aurora have each agreed to extend their previously announced standstill to expire at 5:00 pm (EST) today, and until such time (i)…

CanniMed Postpones Vote to Discuss Aurora Cannabis’ Acquisition

The market responded favorably to CanniMed’s (CMED.TO) (CMMDF) decision to postpone a shareholder vote on its proposed takeover of Newstrike Resources Ltd (HIP.V) (NWKRF) to January 25th.Canadian cannabis producer CanniMed postponed the vote to discuss a possible transaction with rival producer Aurora Cannabis (ACB.TO) (ACBFF) and we are favorable on…

Older Posts »

Search Again